Literature DB >> 26058028

Recent advances on ocular Demodex infestation.

Anny M S Cheng1, Hosam Sheha, Scheffer C G Tseng.   

Abstract

PURPOSE OF REVIEW: To summarize recent advances on ocular Demodex infestation. RECENT
FINDINGS: Demodex infestation is a potential cause of ocular surface inflammation. The pathogenesis of Demodex in eliciting ocular surface inflammation has been further clarified. Cliradex is currently the treatment of choice, it comprises the most active ingredient of tea tree oil, that is terpinen-4-ol, which helps eradicate Demodex mites and reduce ocular surface inflammation.
SUMMARY: Ocular demodicosis is a common but overlooked eye disease that manifests a number of morbidities. Demodex folliculorum causes chronic anterior blepharitis whereas Demodex brevis causes posterior blepharitis, meibomian gland dysfunction, recurrent chalazia, and refractory keratoconjunctivitis. The lash sampling and microscopic counting method and in-vivo confocal microscopy are key diagnostic methods. Cliradex shows promising potential to reduce Demodex counts with additional antibacterial, antifungal, and anti-inflammatory actions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26058028     DOI: 10.1097/ICU.0000000000000168

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  32 in total

Review 1.  Ocular surface inflammation impairs structure and function of meibomian gland.

Authors:  Shin Mizoguchi; Hiroki Iwanishi; Reiko Arita; Kumi Shirai; Takayoshi Sumioka; Masahide Kokado; James V Jester; Shizuya Saika
Journal:  Exp Eye Res       Date:  2017-10       Impact factor: 3.467

2.  The association between demodex infestation and ocular surface manifestations in meibomian gland dysfunction.

Authors:  Xiao-Bo Zhang; Ying-Hui Ding; Wei He
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

Review 3.  [Treatment options for chronic blepharitis considering current evidence].

Authors:  C Auw-Hädrich; T Reinhard
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

4.  Prevalence of Demodex folliculorum and Demodex brevis in patients with blepharitis and chalazion.

Authors:  Serife Akkucuk; Ozlem Makbule Kaya; Lokman Aslan; Talat Ozdemir; Ugur Uslu
Journal:  Int Ophthalmol       Date:  2022-10-18       Impact factor: 2.029

5.  Occurrence of Demodex species in patients with blepharitis and in healthy individuals: a 10-year observational study.

Authors:  Monika Maria Biernat; Jolanta Rusiecka-Ziółkowska; Elżbieta Piątkowska; Iwona Helemejko; Paweł Biernat; Grażyna Gościniak
Journal:  Jpn J Ophthalmol       Date:  2018-09-25       Impact factor: 2.447

6.  Demodex treatment in external ocular disease: the outcomes of a Tasmanian case series.

Authors:  Stephen G Nicholls; Carmen L Oakley; Andrea Tan; Brendan J Vote
Journal:  Int Ophthalmol       Date:  2016-02-02       Impact factor: 2.031

7.  Tea tree oil for Demodex blepharitis.

Authors:  Keyur Savla; Jimmy T Le; Andrew D Pucker
Journal:  Cochrane Database Syst Rev       Date:  2020-06-20

Review 8.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367

9.  Effects of Terpinen-4-ol on Meibomian Gland Epithelial Cells In Vitro.

Authors:  Di Chen; Jingyi Wang; David A Sullivan; Wendy R Kam; Yang Liu
Journal:  Cornea       Date:  2020-12       Impact factor: 3.152

10.  Satisfaction and convenience of using terpenoid-impregnated eyelid wipes and teaching method in people without blepharitis.

Authors:  Tian Yu Qiu; Sharon Yeo; Louis Tong
Journal:  Clin Ophthalmol       Date:  2018-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.